美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
60505-6236-6	60505-6236	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate	Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20211105	N/A	ANDA	ANDA207384	Apotex Corp.	DEFEROXAMINE MESYLATE	500 mg/1	4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6236-6)
68083-173-01	68083-173	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate	Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20171009	N/A	ANDA	ANDA207384	Gland Pharma Limited	DEFEROXAMINE MESYLATE	2 g/1	4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68083-173-01)
68083-172-01	68083-172	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate	Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20171009	N/A	ANDA	ANDA207384	Gland Pharma Limited	DEFEROXAMINE MESYLATE	500 mg/1	4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68083-172-01)
60505-6237-6	60505-6237	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate	Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20211105	N/A	ANDA	ANDA207384	Apotex Corp.	DEFEROXAMINE MESYLATE	2 g/1	4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6)